基于药品全生命周期管理的药品流通监管机制研究  

Research on Drug Circulation Supervision Mechanism Based on Drug Life Cycle Management

作　　者：李鸿娥 韩耀强 王雪莲 郭婧 LI Hong'e;HAN Yaoqiang;WANG Xuelian;GUO Jing(Gansu Provincial Food and Drug Administration Review and Inspection Center(Gansu Provincial Vaccine Inspection Center),Lanzhou,Gansu Province,730000 China)

机构地区：[1]甘肃省药品监督管理局审核查验中心(甘肃省疫苗检查中心),甘肃兰州730000

出　　处：《中国卫生产业》2024年第1期92-95,共4页China Health Industry

摘　　要：药品全生命周期管理是一个全面、系统的过程,涵盖了药品从研发、生产、流通到使用的各个环节。在这个过程中,药品流通监管是确保药品质量和安全的关键环节。随着医药行业的快速发展和监管政策的不断完善,药品流通监管机制的重要性日益凸显。本文旨在研究基于药品全生命周期管理的药品流通监管机制,为药品监管部门和相关企业提供有益的参考和借鉴。Drug life cycle management is a comprehensive and systematic process,covering all aspects of drugs from research and development,production,circulation to use.In this process,the drug circulation supervision is a key link in ensuring drug quality and safety.With the rapid development of the pharmaceutical industry and the continuous im-provement of regulatory policies,the importance of the drug circulation regulatory mechanism has become increasingly prominent.This article aims to study the drug circulation supervision mechanism based on the full life cycle manage-ment of drugs,and provide useful reference and reference for drug regulatory authorities and related enterprises.

关 键 词：药品全生命周期管理 药品流通 药品监管 

分 类 号：R19[医药卫生—卫生事业管理]